{
  "topic": "Team Selection",
  "timestamp": "2025-12-24T17:08:18.781029",
  "summary_text": "The meeting of the AlzKB Implementation Team has concluded. The Scientific Critic\u2019s feedback has been integrated to ensure that the Knowledge Graph does not merely aggregate data, but harmonizes it with clinical and biological rigor. \n\n### Meeting Summary & Actionable Decisions\n\n1.  **Clinical Scale Harmonization:** We have moved beyond simple entity resolution. The Integration Engineer is now mandated to implement mathematical transformation layers to harmonize disparate clinical instruments (e.g., MMSE to MoCA conversions) to ensure longitudinal consistency across ADNI and ROSMAP.\n2.  **Evidence Weighting & Bias Mitigation:** To prevent the \"Matthew Effect\" (popularity bias of genes like *APOE*), the Discovery Specialist will utilize the Evidence Code Ontology (ECO) to weight edges. This ensures that computationally predicted associations are clearly distinguished from those validated by post-mortem histopathology.\n3.  **AD-Specific Semantic Extensions:** The Ontology Architect will not only map to standard ontologies but will also develop micro-ontologies for AD-specific phenotypes (e.g., separating specific amyloid-beta proteoforms) that are currently underserved by broad standards like SNOMED CT.\n4.  **Ground-Truth Benchmarking:** The team has agreed that the primary validation metric for the graph\u2019s predictive power will be its alignment with neuropathological \"gold standard\" data (Braak staging, Thal phases) rather than just clinical diagnosis.\n\n---\n\n### Final Revised Agent Definitions\n\n```python\nagent_ontology_architect = Agent(\n    title=\"Lead Ontology & Semantic Architect\",\n    system_prompt=\"\"\"You are the Lead Ontology & Semantic Architect for AlzKB. \nYour primary responsibility is to define the formal schema and semantic rigor of the Knowledge Graph. \nRoles & Responsibilities:\n1. Map entities to standard biomedical ontologies (SNOMED CT, GO, Mondo, ChEBI).\n2. Develop AD-specific micro-ontologies and extensions to capture granular phenotypes (e.g., specific tau strains, proteoforms, and early vs. late-onset subtypes) that standard ontologies lack.\n3. Define strict edge properties including directionality and predicate logic (e.g., 'causally_linked_to', 'part_of_pathology').\n4. Enforce semantic consistency to prevent redundant entities and ensure the RDF/OWL structure supports high-complexity SPARQL/Cypher queries.\nYour focus is on structural rigor, semantic granularity, and interoperability.\"\"\"\n)\n\nagent_integration_engineer = Agent(\n    title=\"Multi-Modal Data & Clinical Harmonization Engineer\",\n    system_prompt=\"\"\"You are the Multi-Modal Data & Clinical Harmonization Engineer for AlzKB.\nYour responsibility is the precision-alignment of multi-omic and clinical datasets (ADNI, AMP-AD, ROSMAP).\nRoles & Responsibilities:\n1. Construct ETL pipelines that prioritize precision, filtering for high-confidence associations with clear provenance.\n2. Implement clinical scale harmonization to map disparate assessment tools (MMSE, MoCA, CDR) to a unified metric, preventing semantic drift in longitudinal data.\n3. Perform Entity Resolution across multi-modal datasets, ensuring genetic biomarkers are accurately linked to individual clinical phenotypes.\n4. Validate graph edges against neuropathological 'gold standard' ground-truth data (e.g., Braak staging and amyloid PET) to ensure biological accuracy.\nYour focus is on data fidelity, cross-cohort harmonization, and ground-truth validation.\"\"\"\n)\n\nagent_translational_discovery_lead = Agent(\n    title=\"Translational RAG & Evidence Specialist\",\n    system_prompt=\"\"\"You are the Translational RAG & Evidence Specialist for AlzKB.\nYour responsibility is to optimize the KG for discovery while mitigating literature bias and hallucinations.\nRoles & Responsibilities:\n1. Develop retrieval strategies (GraphRAG) that use the Evidence Code Ontology (ECO) to weight associations based on experimental confidence.\n2. Implement bias mitigation algorithms to ensure discovery modules do not disproportionately favor 'celebrity genes' (e.g., APOE, APP) at the expense of novel targets.\n3. Ingest negative results and non-significant associations to provide a balanced view of the biological landscape, preventing the RAG from mirroring consensus-only biases.\n4. Design discovery workflows that check RAG-generated hypotheses against the KG's factual edges to strictly prevent the propagation of unsupported scientific claims.\nYour focus is on clinical utility, bias-aware discovery, and evidence-based precision.\"\"\"\n)\n```\n\n**Next Phase:** The Integration Engineer will present the first iteration of the Cross-Cohort Harmonization protocol for ROSMAP and ADNI datasets. The meeting is adjourned.",
  "summary_structured": {
    "decisions": [
      "Integrate clinical scale harmonization protocols to unify disparate instruments across ADNI and ROSMAP cohorts.",
      "Adopt the Evidence Code Ontology (ECO) to weight edges and mitigate 'celebrity gene' popularity bias.",
      "Mandate the development of AD-specific micro-ontologies for granular phenotypic representation.",
      "Establish neuropathological gold standards as the primary validation metric for graph integrity."
    ],
    "action_items": [
      "Create AD-specific extensions for SNOMED CT and GO (Lead Ontology & Semantic Architect)",
      "Develop mathematical mapping for MMSE/MoCA/CDR harmonization (Multi-Modal Data & Clinical Harmonization Engineer)",
      "Design bias-mitigating discovery algorithms and ECO-weighted RAG layers (Translational RAG & Evidence Specialist)",
      "Benchmark initial graph edges against post-mortem histopathology datasets (Multi-Modal Data & Clinical Harmonization Engineer)"
    ],
    "status": "COMPLETE",
    "key_context": "The AlzKB project has finalized its core agent team with a focus on solving clinical data heterogeneity and literature bias. The implementation phase will now prioritize the creation of a validated, harmonized knowledge structure grounded in neuropathological evidence rather than simple clinical observation."
  }
}